top of page
  • INSIGHT communications team

INSIGHT and other health data hubs demonstrate 18-month impact

In the 18 months since their launch, the UK's Health Data Research Hubs have shown that data can make a difference to patients' lives. They have just passed an official assessment by Health Data Research UK (HDR UK), demonstrating their ability to combine industry collaboration and public involvement with targeted research to produce an agile response to the COVID-19 pandemic.

Here at INSIGHT, we have been able to show the impact of the pandemic on age-related macular degeneration (AMD). By analysing existing clinical trial data from our industry partner, Roche-Genentech, and combining it with data from University Hospitals Birmingham and Moorfields, we have been able to provide reliable estimates of the impact on patients' vision resulting from delays to treatment in those newly diagnosed with wet AMD.

Alastair Denniston, Director of the INSIGHT Health Data Research Hub for Eye Health, said:

“I am particularly proud of the way INSIGHT has been able to adapt our unique cross-sector partnership to respond to the some of the challenges posed by COVID-19 to eye care in the NHS. By combining the expertise of our industry partner, Roche-Genentech, with unrivalled sets of anonymised patient data from INSIGHT, we’ve been able to predict the impact of the pandemic on patients with wet AMD. This kind of information is critical in helping us to optimise the NHS to optimise patient care as services begin to return to normal across the country.”

Find out more on the Health Data Research UK website:


bottom of page